SCHEMBL30901955

SCHEMBL30901955

CNC(=O)C(C)(C)Oc1ccc(F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 2/20 0.47
▸ PPARA Q07869 10/20 0.46
▸ CYP1A2 P05177 3/20 0.43
▸ CYP3A4 P08684 3/20 0.43
▸ CYP2C19 P33261 3/20 0.43
▸ CYP2D6 P10635 2/20 0.43
▸ CYP2C9 P11712 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ MMP1 P03956 1/20 0.41
▸ MMP2 P08253 1/20 0.41
▸ MMP9 P14780 1/20 0.41
▸ MMP13 P45452 1/20 0.41
▸ PPARG P37231 3/20 0.41
▸ GAA P10253 1/20 0.41
▸ PPARD Q03181 2/20 0.40
▸ ADORA3 P0DMS8 1/20 0.39
▸ ADORA2A P29274 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1417538 0.84 ALDH1A1 (0.49) CNR1PPARACYP1A2CYP3A4CYP2C19
SCHEMBL4429153 0.84 MEN1 (0.49) PPARACYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL3237160 0.82 MAPT (0.50) PPARACYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL20133460 0.82 PPARA (0.46) CNR1PPARACYP1A2CYP3A4CYP2C19
SCHEMBL21991451 0.80 PPARA (0.46) CNR1PPARACYP1A2CYP3A4CYP2C19
SCHEMBL3158911 0.79 PPARA (0.67) PPARACYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL11550869 0.78 PPARA (0.50) CNR1PPARACYP1A2CYP3A4CYP2C19
SCHEMBL4688589 0.78 PPARA (0.48) CNR1PPARACYP1A2CYP3A4CYP2C19
SCHEMBL24542744 0.78 CYP1A2 (0.53) PPARACYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL19696240 0.77 CYP3A4 (0.50) PPARACYP1A2CYP3A4CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240132450-A1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 ACADIA PHARMACEUTICALS INC. 2024-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240132450-A1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 GPR88, GPR65, GPR68 CNR1 102/4885PPARA 355/4885CYP1A2 2070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback